Advances in drug treatment of retinal vein occlusion
Author:
Corresponding Author:

Affiliation:

Clc Number:

Fund Project:

National Natural Science Foundation of China(No.81500724); The Social Development of Science and Technology Research Project of Shaanxi(No.2016SF-063)

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Retinalvein occlusion(RVO)is the most common retinal vascular disease. The main causes of visual impairment and blindness are macular edema and retinal neovascularization. Drug therapies are the effective and safe method in the treatment of RVO currently. The main drugs conclude corticosteroid drugs, anti-vascular endothelial growth factor drugs, thrombolytic drugs and traditional drugs. This article reviews the recent progress in RVO in order to provide some valuable references for clinical treatment.

    Reference
    Related
    Cited by
Get Citation

Pan Long, Yi-Bing Wu, Jian Zhao, et al. Advances in drug treatment of retinal vein occlusion. Guoji Yanke Zazhi( Int Eye Sci) 2017;17(11):2055-2059

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:July 05,2017
  • Revised:September 22,2017
  • Adopted:
  • Online: October 19,2017
  • Published: